PharmExec Blog

Pricing and Reimbursement in Europe: Where Does Innovation Fit?

By Leela Barham.

It was recently said, in reference to the UK’s Value-Based Assessment(VBA) program, that innovation had not been “tried and tested in the pricing context”, which explains the loss of the “innovation” criteria from the proposals formerly known as Value-Based Pricing (VBP). This prompted me to think about just how has innovation been part of pricing and reimbursement of medicines. Read More »

Posted in Europe, Global, Guest Blog, pricing, R&D | Tagged , , , , , | Leave a comment

UK: Lord Saatchi's Innovation Bill Divides Healthcare Community

By Leela Barham.

Few would argue with the desirability of innovation — something new, something that delivers value. And innovation in pharmaceuticals is a range from a more convenient way for patients to take a medicine, to treating a disease that couldn’t be treated before.

Pretty much everyone will agree that not only do they want innovation, and more of it, but identifying what stops or hinders innovation is where people’s opinions often diverge.

According to the UK’s Lord Saatchi, one of the problems for innovation in medicine (and surgery) is the legal framework — so-called ‘defensive medicine’. Doctors might not be innovating in treatment or surgery for fear of prosecution, he says. And his Medical Innovation Bill is underpinned by this view. Read More »

Posted in Europe, Global, Guest Blog, Regulatory | Tagged , , | Leave a comment

The Fort Hood Killing and Psychotropic Drugs

In response to the recent shooting at Fort Hood that killed four (including the killer’s suicide) and wounded 16, the mental health watchdog Citizens Commission on Human Rights (CCHR) views this and other recent incidents as a wake-up call to the dangers of antidepressants, anti-psychotics and anti-anxiety drugs, which between them have accumulated 22 international drug regulatory warnings for causing violent and even homicidal behavior. Read More »

Posted in Safety | Tagged , , , | Leave a comment

Online Patient Library Set for European Launch

By Philip Ward.

The new Internet Library from the European Patients’ Academy (EUPATI) will come online towards the end of 2015, and will be available in seven European languages (English, French, Spanish, Italian, German, Polish and Russian), project director Jan Geissler revealed at last week’s workshop held in Warsaw, Poland, and organized by EUPATI. Read More »

Posted in Europe, healthcare, Patient Communication, patient education | Tagged , , , , , | Leave a comment

Digital Education a Key Bridge to Tapping Emerging Markets

In our second Q&A installment previewing next month’s iPharma2014 conference in New York City, we spoke with David Stern, executive VP of global commercial operations with OvaScience. Stern will be presenting on “Going Global – Innovative Tactics to Engage Emerging Markets and Extend the Global Strategy to a Regional Level.” Drawing from his time as an executive at Merck Serono, Stern will present some general examples of ways pharma companies can engage regions worldwide, including emerging markets. Stern served as head of Merck Serono’s fertility global business franchise before joining OvaScience earlier this year. Read More »

Posted in Emerging Markets, Global, healthcare, Medical Education, Patient Communication, Strategy | Tagged , , , , | Leave a comment
  • Categories

  • Meta